SG11201407346WA - Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent - Google Patents

Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent

Info

Publication number
SG11201407346WA
SG11201407346WA SG11201407346WA SG11201407346WA SG11201407346WA SG 11201407346W A SG11201407346W A SG 11201407346WA SG 11201407346W A SG11201407346W A SG 11201407346WA SG 11201407346W A SG11201407346W A SG 11201407346WA SG 11201407346W A SG11201407346W A SG 11201407346WA
Authority
SG
Singapore
Prior art keywords
international
treatment
chemically modified
agent
heparan sulphate
Prior art date
Application number
SG11201407346WA
Other languages
English (en)
Inventor
Gunvor Ekman-Ordeberg
Anders Malmström
Original Assignee
Dilafor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dilafor Ab filed Critical Dilafor Ab
Publication of SG11201407346WA publication Critical patent/SG11201407346WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201407346WA 2012-05-08 2013-05-07 Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent SG11201407346WA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261644036P 2012-05-08 2012-05-08
US201261668150P 2012-07-05 2012-07-05
PCT/SE2013/050510 WO2013169194A1 (fr) 2012-05-08 2013-05-07 Traitement d'une hémorragie post partum avec de l'héparine ou du sulfate d'héparane chimiquement modifiés et un agent utérotonique

Publications (1)

Publication Number Publication Date
SG11201407346WA true SG11201407346WA (en) 2014-12-30

Family

ID=49551063

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201407346WA SG11201407346WA (en) 2012-05-08 2013-05-07 Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent

Country Status (16)

Country Link
US (1) US20150099703A1 (fr)
EP (1) EP2846810A4 (fr)
JP (1) JP2015516415A (fr)
CN (1) CN104284667A (fr)
AU (1) AU2013260209A1 (fr)
BR (1) BR112014027712B1 (fr)
CA (1) CA2868403A1 (fr)
HK (1) HK1203377A1 (fr)
IL (1) IL234752A0 (fr)
MX (1) MX2014013449A (fr)
MY (1) MY192330A (fr)
NZ (1) NZ701419A (fr)
RU (1) RU2014149230A (fr)
SG (1) SG11201407346WA (fr)
UA (1) UA117912C2 (fr)
WO (1) WO2013169194A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230144378A1 (en) 2020-02-17 2023-05-11 Dilafor Ab Tafoxiparin for the treatment of preeclampsia
TW202406559A (zh) 2022-05-03 2024-02-16 瑞典商迪拉佛公司 塔夫西肝素(tafoxiparin)之新穎醫藥用途
EP4272749A1 (fr) 2022-05-03 2023-11-08 Dilafor AB Nouvelle utilisation médicale de tafoxiparine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993810A (en) * 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
US8071569B2 (en) * 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
UA21707U (en) * 2006-12-18 2007-03-15 Valerii Ivanovych Linnikov Method for preventing and treating thrombophilia in course of gestation and postpartum
WO2009073184A1 (fr) * 2007-12-03 2009-06-11 Florida State University Research Foundation, Inc. Compositions pour induire le travail et procédés associés
JO3400B1 (ar) * 2010-09-30 2019-10-20 Ferring Bv مركب صيدلاني من كاربيتوسين
CN104144950B (zh) * 2011-12-19 2017-09-05 迪乐方有限责任公司 含有重复的二糖单元的非抗凝的葡糖胺聚糖及其医药用途
US20150057226A1 (en) * 2012-03-26 2015-02-26 Dilafor Ab Method for treatment of labor arrest
CN104203256B (zh) * 2012-03-26 2017-11-24 迪乐方有限责任公司 用于引产的包含硫酸化的葡糖胺聚糖的联合治疗

Also Published As

Publication number Publication date
EP2846810A4 (fr) 2016-04-13
NZ701419A (en) 2016-04-29
BR112014027712B1 (pt) 2023-12-19
AU2013260209A1 (en) 2014-11-20
US20150099703A1 (en) 2015-04-09
CA2868403A1 (fr) 2013-11-14
MY192330A (en) 2022-08-17
UA117912C2 (uk) 2018-10-25
EP2846810A1 (fr) 2015-03-18
BR112014027712A2 (pt) 2017-06-27
MX2014013449A (es) 2014-12-08
IL234752A0 (en) 2014-11-30
HK1203377A1 (en) 2015-10-30
JP2015516415A (ja) 2015-06-11
WO2013169194A1 (fr) 2013-11-14
RU2014149230A (ru) 2016-06-27
CN104284667A (zh) 2015-01-14

Similar Documents

Publication Publication Date Title
SG11201907034PA (en) Methods of treating influenza
SG11201809912UA (en) Hybrid carriers for nucleic acid cargo
SG11201811431VA (en) Multispecific antibodies against cd40 and cd137
SG11201907744QA (en) Replacement of cytotoxic preconditioning before cellular immunotherapy
SG11201805120YA (en) Zika virus vaccine
SG11201407200TA (en) Liquid formulation
SG11201807913XA (en) Stabilized soluble pre-fusion rsv f proteins
SG11201407873RA (en) Endoscopic sympathectomy systems and methods
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201408777WA (en) Degradable filter for smoking articles
SG11201811706RA (en) Process for the preparation of microcapsules
SG11201904535VA (en) Prevention and treatment of bone and cartilage damage or disease
SG11201407536UA (en) Topical pharmaceutical compositions comprising terbinafine and urea
SG11201807185UA (en) Modified hyaluronic acid, method for making same and uses thereof
SG11201901534VA (en) Combination therapy with controlled-release cnp agonists
SG11201805001UA (en) Method of treating influenza a
SG11201900021PA (en) Methods and compositions for the treatment of cancer
SG11201408509PA (en) Racecadotril lipid compositions
SG11201810786RA (en) [bis(trihydrocarbylsilyl)aminosilyl]-functionalized styrene and a method for its preparation
SG11201810078PA (en) Stabilized pre-fusion rsv f proteins
SG11201903770UA (en) Combination treatments comprising imidazopyrazinones for the treatment of psychiatric and/or cognitive disorders
SG11201811580SA (en) Compositions, devices, and methods for the treatment of alcohol use disorder
SG11201407597XA (en) Nucleophilic catalysts for oxime linkage
SG11201810192TA (en) Antibacterial compositions
SG11201908513RA (en) Peptides for treatment of diabetes